Table 1A.

Demographic data, giant cell arteritis (GCA) diagnosis, and reason for tocilizumab (TCZ) treatment in 34 patients.

Demographic DataGCA DiagnosisDisease Length before TCZ, MosReason for TCZ Treatment
Pt.Age/sexTABACR criteriaImaging proof of vasculitisGC side effects/dependenceFailure of other drugsDisease severity
177/F+Yes18Yes
274/F+Yes9Yes
375/M+Yes4Yes
466/F+YesUS of TA72YesMTX
565/F+Yes6Yes
676/M+Yes12YesMTX
778/F+Yes11YesMTX
878/FNoPET scan107Yes
966/F+Yes84Yes
1068/M+YesPET scan40YesMTX, AZA, LEF
1163/F+Yes36YesMTX
1254/FNoPET scan7YesIFX, MTX
1358/FYesPET scan27YesMTX
1455/FYes36Yesanakinra, dapsone, MTX
1563/FYesPET scan15Yes
1673/F+Yes22YesIFX
1767/FYes31Yes
1876/F+YesPET scan5Yes
1972/F+Yes11YesMTX
2080/MNoUS of TA3YesMTX
2160/FNoPET scan10YesMTX
2274/F+Yes11YesIFX, ADA
2363/F+Yes17YesMTX
2470/F+YesPET scan5YesMTX
2566/MYes5Yes
2676/F+Yes2YesMTX
2786/F+Yes0NoYes
2860/F+YesPET scan2YesMTX
2986/F+Yes1YesMTX
3078/F+Yes1YesMTX
3178/MYes1YesMTX
3266/F+Yes1Yes
3378/F+Yes0NoYes
3474/M+Yes0No
  • ACR: American College of Rheumatology; AZA: azathioprine; MTX: methotrexate; TA: temporal artery; TAB: temporal artery biopsy; PET scan: positron emission tomography scanner; US: ultrasound; IFX: infliximab; ADA: adalimumab; LEF: leflunomide.